Definium Therapeutics Appoints Roger Adsett to Board of Directors
Definium Therapeutics (DFTX) announced the appointment of Roger Adsett to its Board of Directors. Adsett currently serves as COO of Insmed (INSM). The appointment increases the board from six to seven directors.
